| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |